Pain Management

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA Alert
fda alert
FDA Alert
FDA Approves First Nalmefene Hydrochloride Auto-Injector to Reverse Opioid Overdose
08/23/2024
The first nalmefene hydrochloride auto-injector is another emergency treatment tool to reverse known or suspected opioid overdose.
08/23/2024
FDA Roundup
FDA
FDA Roundup
Key FDA Approvals on Novel Treatment Options for Menopausal Hot Flashes, CDI, Opioid Overdoses, and More
06/13/2023
This FDA Roundup includes an at-a-glance look at the latest FDA drug approvals in April and May, including treatment for menopausal hot flashes, Clostridioides difficile infection, suspected opioid...
06/13/2023
FDA Roundup
FDA
FDA Roundup
Key FDA Approvals on Novel Treatment Options for Menopausal Hot Flashes, CDI, Opioid Overdoses, and More
06/13/2023
This FDA Roundup includes an at-a-glance look at the latest FDA drug approvals in April and May, including treatment for menopausal hot flashes, Clostridioides difficile infection, suspected opioid...
06/13/2023
FDA
FDA
FDA Approves Neurostimulation System for Chronic Low Back Pain
06/23/2020
The FDA has approved an implantable neurostimulation system designed for the treatment of intractable chronic low back pain associated with multifidus muscle dysfunction.
06/23/2020
Knee pain
Knee pain
FDA Approves Extended-Release Intra-Articular Injection
10/10/2017
After results from a clinical trial demonstrated its safety and efficacy, the US Food and Drug Administration recently approved the first and only extended-release intra-articular injection for patients...
10/10/2017
cardiovascular disease
cardiovascular disease
FDA Strengthens NSAID Cardiovascular Warnings
07/10/2015
The FDA has decided to strengthen existing cardiovascular warnings on the labels of prescription non-aspirin nonsteroidal anti-inflammatory drugs.
07/10/2015
Treatment
Treatment
FDA Releases Final Guidance On Abuse-Deterrent Opioids
04/02/2015
The FDA has released its finalized industry guidance for the development of abuse-deterring opioid drugs.
04/02/2015